{"hands_on_practices": [{"introduction": "The interaction between a ligand and its receptor is the initiating event of most signaling pathways. In a physiological context, and especially in pharmacology, a receptor is often exposed to multiple molecules that can bind to the same site. This practice challenges you to derive, from first principles, the foundational equation describing competitive binding at equilibrium [@problem_id:2545440]. Mastering this derivation provides the quantitative framework for understanding how therapeutic antagonists compete with endogenous agonists, a cornerstone of drug action and design.", "problem": "A synaptic G protein-coupled receptor (GPCR) on a neuron has a single orthosteric binding site that can bind either the endogenous neurotransmitter $L_1$ (agonist) or a synthetic competitor $L_2$ (antagonist), but not both simultaneously. Assume the system is at equilibrium, follows the law of mass action, and that $[L_1]$ and $[L_2]$ denote the free equilibrium concentrations of the ligands in the extracellular space. Let $K_{d1}$ and $K_{d2}$ be the equilibrium dissociation constants for $L_1$ and $L_2$ binding to the receptor, respectively. Define the total receptor concentration as $[R_{\\text{tot}}]$ and the receptor–ligand complex concentrations as $[RL_1]$ and $[RL_2]$.\n\nStarting only from the definitions of the equilibrium dissociation constants and conservation of receptor mass, derive the fractional occupancy of the receptor by $L_1$, denoted $f_1$, as a closed-form analytic expression in terms of $[L_1]$, $[L_2]$, $K_{d1}$, and $K_{d2}$. Provide your final answer as a single expression for $f_1$. No numerical evaluation or rounding is required.", "solution": "The problem statement has been evaluated and is found to be valid. It is a scientifically grounded, well-posed, and objective problem describing a classic case of competitive ligand binding, a fundamental concept in biochemistry and an elementary application of the law of mass action. We may proceed with the derivation.\n\nThe objective is to derive the fractional occupancy of the receptor by the ligand $L_1$, which is denoted $f_1$. This is defined as the ratio of the concentration of receptor-ligand-$1$ complex, $[RL_1]$, to the total concentration of receptors, $[R_{\\text{tot}}]$.\n$$f_1 = \\frac{[RL_1]}{[R_{\\text{tot}}]}$$\nThe total receptor concentration is the sum of the concentrations of free (unbound) receptors, $[R]$, and receptors bound to each of the two ligands:\n$$[R_{\\text{tot}}] = [R] + [RL_1] + [RL_2]$$\nThe system is at equilibrium, so the interactions are governed by the equilibrium dissociation constants. For the binding of $L_1$ and $L_2$, these are defined as:\n$$K_{d1} = \\frac{[R][L_1]}{[RL_1]}$$\n$$K_{d2} = \\frac{[R][L_2]}{[RL_2]}$$\nwhere $[L_1]$ and $[L_2]$ are the free concentrations of the respective ligands.\n\nTo derive an expression for $f_1$, we must express all concentrations in the receptor mass balance equation in terms of a single variable. It is most efficient to express them in terms of $[RL_1]$, as this term appears in the numerator of the definition of $f_1$.\n\nFrom the definition of $K_{d1}$, we can express the concentration of free receptor, $[R]$, as:\n$$[R] = \\frac{K_{d1}[RL_1]}{[L_1]}$$\nNext, we express the concentration of the receptor-ligand-$2$ complex, $[RL_2]$, in terms of $[RL_1]$. From the definition of $K_{d2}$, we have $[RL_2] = \\frac{[R][L_2]}{K_{d2}}$. Substituting the expression for $[R]$ derived above gives:\n$$[RL_2] = \\left(\\frac{K_{d1}[RL_1]}{[L_1]}\\right)\\frac{[L_2]}{K_{d2}} = [RL_1]\\left(\\frac{K_{d1}[L_2]}{K_{d2}[L_1]}\\right)$$\nNow we substitute the expressions for $[R]$ and $[RL_2]$ into the equation for the conservation of total receptor mass:\n$$[R_{\\text{tot}}] = \\frac{K_{d1}[RL_1]}{[L_1]} + [RL_1] + [RL_1]\\left(\\frac{K_{d1}[L_2]}{K_{d2}[L_1]}\\right)$$\nWe factor out the common term $[RL_1]$ from the right-hand side of the equation:\n$$[R_{\\text{tot}}] = [RL_1] \\left( 1 + \\frac{K_{d1}}{[L_1]} + \\frac{K_{d1}[L_2]}{K_{d2}[L_1]} \\right)$$\nNow, we can find the fractional occupancy $f_1$ by taking the ratio of $[RL_1]$ to $[R_{\\text{tot}}]$:\n$$f_1 = \\frac{[RL_1]}{[R_{\\text{tot}}]} = \\frac{[RL_1]}{[RL_1] \\left( 1 + \\frac{K_{d1}}{[L_1]} + \\frac{K_{d1}[L_2]}{K_{d2}[L_1]} \\right)}$$\nThe term $[RL_1]$ cancels, leaving:\n$$f_1 = \\frac{1}{1 + \\frac{K_{d1}}{[L_1]} + \\frac{K_{d1}[L_2]}{K_{d2}[L_1]}}$$\nTo simplify this expression and eliminate the compound fractions, we multiply the numerator and the denominator by $[L_1]$:\n$$f_1 = \\frac{[L_1]}{[L_1] \\left( 1 + \\frac{K_{d1}}{[L_1]} + \\frac{K_{d1}[L_2]}{K_{d2}[L_1]} \\right)} = \\frac{[L_1]}{[L_1] + K_{d1} + \\frac{K_{d1}[L_2]}{K_{d2}}}$$\nThis expression is correct, but it is conventional to group the terms related to the antagonist $L_2$. We can factor the term $K_{d1}$ in the denominator to achieve the standard form:\n$$f_1 = \\frac{[L_1]}{[L_1] + K_{d1}\\left(1 + \\frac{[L_2]}{K_{d2}}\\right)}$$\nThis is the final, closed-form analytic expression for the fractional occupancy of the receptor by the ligand $L_1$ in the presence of a competitive antagonist $L_2$. This equation is a form of the Gaddum equation, which describes competitive antagonism.", "answer": "$$\\boxed{\\frac{[L_1]}{[L_1] + K_{d1}\\left(1 + \\frac{[L_2]}{K_{d2}}\\right)}}$$", "id": "2545440"}, {"introduction": "While equilibrium analysis describes the eventual state of a system, the timing of cellular responses is governed by kinetics. The speed at which a receptor becomes occupied by its ligand determines how quickly a cell can react to a signal, a critical factor in fast-acting systems like the nervous and immune systems. This exercise transitions from the static picture of equilibrium to the dynamic process of binding over time, asking you to calculate the timescale for receptor occupancy [@problem_id:2545449]. This analysis is essential for understanding how cells interpret transient or rapidly changing signals.", "problem": "A well-stirred hippocampal slice preparation is rapidly perfused at time $t=0$ with a constant concentration step of the complement fragment ligand $C5a$ to a maintained bath concentration $L_0$. Microglial cells express the complement component $5a$ receptor $1$ (C5aR1), and ligand binding follows mass-action kinetics in the extracellular volume. Let $R(t)$ denote the concentration of unbound receptor, $C(t)$ the concentration of receptor–ligand complex, and $R_{\\mathrm{tot}}$ the total receptor concentration on the cell surface, with the conservation relation $R_{\\mathrm{tot}} = R(t) + C(t)$. The ligand concentration is clamped at $L(t) = L_0$ for all $t \\ge 0$ by fast perfusion. Binding and unbinding are characterized by an association rate constant $k_{\\mathrm{on}}$ and dissociation rate constant $k_{\\mathrm{off}}$. Assume that diffusion is fast enough to maintain spatial homogeneity, and that prior to $t=0$ there is no ligand present and no complex ($C(0)=0$).\n\nStarting only from mass-action kinetics and receptor conservation, determine the time $t_{0.90}$ required for the complex concentration $C(t)$ to reach $0.90$ of its equilibrium value after the step to $L_0$. Use the parameter values $k_{\\mathrm{on}} = 2.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$, $k_{\\mathrm{off}} = 1.0 \\times 10^{-2}\\ \\mathrm{s}^{-1}$, $R_{\\mathrm{tot}} = 1.0 \\times 10^{-10}\\ \\mathrm{M}$, and $L_0 = 5.0 \\times 10^{-9}\\ \\mathrm{M}$. \n\nRound your final numerical result to $3$ significant figures. Express your final answer in seconds ($\\mathrm{s}$). Your final answer must be a single real number.", "solution": "The problem is validated as scientifically grounded, well-posed, and objective. It is based on the fundamental principles of mass-action kinetics and describes a standard biochemical experiment. All necessary information is provided, and there are no contradictions or ambiguities. I will proceed with the solution.\n\nThe formation of the receptor-ligand complex, $C(t)$, is governed by the law of mass action. The rate of change of the complex concentration, $\\frac{dC}{dt}$, is the difference between the rate of association and the rate of dissociation. The association rate is proportional to the concentrations of the unbound ligand, $L(t)$, and unbound receptors, $R(t)$, with the association rate constant $k_{\\mathrm{on}}$. The dissociation rate is proportional to the concentration of the complex, $C(t)$, with the dissociation rate constant $k_{\\mathrm{off}}$.\nThis gives the differential equation:\n$$\n\\frac{dC}{dt} = k_{\\mathrm{on}} L(t) R(t) - k_{\\mathrm{off}} C(t)\n$$\nThe problem states that the ligand concentration is maintained at a constant value, $L_0$, for all times $t \\ge 0$. So, $L(t) = L_0$. The total receptor concentration, $R_{\\mathrm{tot}}$, is constant and is given by the conservation relation $R_{\\mathrm{tot}} = R(t) + C(t)$. We can express the unbound receptor concentration as $R(t) = R_{\\mathrm{tot}} - C(t)$. Substituting these into the rate equation yields:\n$$\n\\frac{dC}{dt} = k_{\\mathrm{on}} L_0 (R_{\\mathrm{tot}} - C(t)) - k_{\\mathrm{off}} C(t)\n$$\nThis is a first-order linear ordinary differential equation. We can rearrange the terms to group the factors of $C(t)$:\n$$\n\\frac{dC}{dt} = k_{\\mathrm{on}} L_0 R_{\\mathrm{tot}} - (k_{\\mathrm{on}} L_0 + k_{\\mathrm{off}}) C(t)\n$$\nTo solve this equation, we can define an observed rate constant, $k_{\\mathrm{obs}}$, as:\n$$\nk_{\\mathrm{obs}} = k_{\\mathrm{on}} L_0 + k_{\\mathrm{off}}\n$$\nThe differential equation then becomes:\n$$\n\\frac{dC}{dt} = k_{\\mathrm{on}} L_0 R_{\\mathrm{tot}} - k_{\\mathrm{obs}} C(t)\n$$\nThis equation describes the approach to equilibrium. At equilibrium ($t \\to \\infty$), the concentration of the complex is constant, so $\\frac{dC}{dt} = 0$. Let $C_{\\mathrm{eq}}$ be the equilibrium concentration of the complex.\n$$\n0 = k_{\\mathrm{on}} L_0 R_{\\mathrm{tot}} - k_{\\mathrm{obs}} C_{\\mathrm{eq}}\n$$\nSolving for $C_{\\mathrm{eq}}$ gives:\n$$\nC_{\\mathrm{eq}} = \\frac{k_{\\mathrm{on}} L_0 R_{\\mathrm{tot}}}{k_{\\mathrm{obs}}} = \\frac{k_{\\mathrm{on}} L_0 R_{\\mathrm{tot}}}{k_{\\mathrm{on}} L_0 + k_{\\mathrm{off}}}\n$$\nThe differential equation can now be written in terms of $C_{\\mathrm{eq}}$:\n$$\n\\frac{dC}{dt} = k_{\\mathrm{obs}} C_{\\mathrm{eq}} - k_{\\mathrm{obs}} C(t) = k_{\\mathrm{obs}}(C_{\\mathrm{eq}} - C(t))\n$$\nThis is a separable differential equation:\n$$\n\\frac{dC}{C_{\\mathrm{eq}} - C} = k_{\\mathrm{obs}} dt\n$$\nWe integrate both sides. The left side is integrated from the initial concentration $C(0)=0$ to $C(t)$, and the right side from time $t=0$ to $t$:\n$$\n\\int_{0}^{C(t)} \\frac{dC'}{C_{\\mathrm{eq}} - C'} = \\int_{0}^{t} k_{\\mathrm{obs}} dt'\n$$\nThe integral on the left is $-\\ln(C_{\\mathrm{eq}} - C') \\Big|_{0}^{C(t)}$.\n$$\n-\\ln(C_{\\mathrm{eq}} - C(t)) - (-\\ln(C_{\\mathrm{eq}} - 0)) = k_{\\mathrm{obs}} t\n$$\n$$\n-\\ln(C_{\\mathrm{eq}} - C(t)) + \\ln(C_{\\mathrm{eq}}) = k_{\\mathrm{obs}} t\n$$\n$$\n\\ln\\left(\\frac{C_{\\mathrm{eq}}}{C_{\\mathrm{eq}} - C(t)}\\right) = k_{\\mathrm{obs}} t\n$$\nSolving for $C(t)$:\n$$\n\\frac{C_{\\mathrm{eq}}}{C_{\\mathrm{eq}} - C(t)} = \\exp(k_{\\mathrm{obs}} t)\n$$\n$$\nC_{\\mathrm{eq}} - C(t) = C_{\\mathrm{eq}} \\exp(-k_{\\mathrm{obs}} t)\n$$\n$$\nC(t) = C_{\\mathrm{eq}} (1 - \\exp(-k_{\\mathrm{obs}} t))\n$$\nWe need to find the time $t_{0.90}$ at which the complex concentration reaches $0.90$ of its equilibrium value. That is, $C(t_{0.90}) = 0.90 C_{\\mathrm{eq}}$.\n$$\n0.90 C_{\\mathrm{eq}} = C_{\\mathrm{eq}} (1 - \\exp(-k_{\\mathrm{obs}} t_{0.90}))\n$$\nDividing by $C_{\\mathrm{eq}}$ (which is non-zero), we get:\n$$\n0.90 = 1 - \\exp(-k_{\\mathrm{obs}} t_{0.90})\n$$\n$$\n\\exp(-k_{\\mathrm{obs}} t_{0.90}) = 1 - 0.90 = 0.10\n$$\nTaking the natural logarithm of both sides:\n$$\n-k_{\\mathrm{obs}} t_{0.90} = \\ln(0.10) = \\ln(10^{-1}) = -\\ln(10)\n$$\nTherefore, the time $t_{0.90}$ is given by:\n$$\nt_{0.90} = \\frac{\\ln(10)}{k_{\\mathrm{obs}}} = \\frac{\\ln(10)}{k_{\\mathrm{on}} L_0 + k_{\\mathrm{off}}}\n$$\nNow we substitute the given numerical values:\n$k_{\\mathrm{on}} = 2.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$\n$k_{\\mathrm{off}} = 1.0 \\times 10^{-2}\\ \\mathrm{s}^{-1}$\n$L_0 = 5.0 \\times 10^{-9}\\ \\mathrm{M}$\n\nFirst, calculate the observed rate constant $k_{\\mathrm{obs}}$:\n$$\nk_{\\mathrm{obs}} = (2.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}) \\times (5.0 \\times 10^{-9}\\ \\mathrm{M}) + (1.0 \\times 10^{-2}\\ \\mathrm{s}^{-1})\n$$\n$$\nk_{\\mathrm{obs}} = (10.0 \\times 10^{-3}\\ \\mathrm{s}^{-1}) + (1.0 \\times 10^{-2}\\ \\mathrm{s}^{-1})\n$$\n$$\nk_{\\mathrm{obs}} = (1.0 \\times 10^{-2}\\ \\mathrm{s}^{-1}) + (1.0 \\times 10^{-2}\\ \\mathrm{s}^{-1}) = 2.0 \\times 10^{-2}\\ \\mathrm{s}^{-1}\n$$\nNow, calculate $t_{0.90}$:\n$$\nt_{0.90} = \\frac{\\ln(10)}{2.0 \\times 10^{-2}\\ \\mathrm{s}^{-1}} \\approx \\frac{2.302585}{2.0 \\times 10^{-2}}\\ \\mathrm{s}\n$$\n$$\nt_{0.90} \\approx 115.12925\\ \\mathrm{s}\n$$\nThe problem requires rounding the final result to $3$ significant figures.\n$$\nt_{0.90} \\approx 115\\ \\mathrm{s}\n$$\nThis is the time required for the complex concentration to reach $90\\%$ of its final equilibrium value. The total receptor concentration $R_{\\mathrm{tot}}$ was not required for this specific calculation, as the time to reach a fraction of equilibrium depends only on the observed rate constant $k_{\\mathrm{obs}}$ which is independent of $R_{\\mathrm{tot}}$.", "answer": "$$ \\boxed{115} $$", "id": "2545449"}, {"introduction": "Ultimately, the purpose of receptor binding is to elicit a functional response, often through the activation of an enzyme. This final practice integrates the principles of binding and competition directly with enzyme function, using the clinically vital Janus kinase (JAK) as a model system [@problem_id:2545454]. By analyzing how a gain-of-function mutation affects the action of an ATP-competitive inhibitor, you will connect fundamental Michaelis-Menten kinetics to the modern challenges of targeted therapy and personalized medicine. This problem demonstrates how a deep understanding of biochemical principles is crucial for predicting the consequences of genetic variations on drug efficacy.", "problem": "A cytokine-stimulated lymphocyte relies on Janus kinase (JAK) to phosphorylate Signal Transducer and Activator of Transcription (STAT). Consider a gain-of-function JAK mutant that lowers the Michaelis constant for adenosine triphosphate (ATP), $K_m$, without changing the maximum velocity, $V_\\mathrm{max}$. Assume classical steady-state enzyme kinetics apply, that the peptide substrate is saturating so that ATP binding is rate-limiting, and that a small-molecule inhibitor is a purely ATP-competitive binder with inhibitor constant $K_i$. Assume cytosolic ATP is buffered at $[\\mathrm{ATP}] = 1.0\\,\\mathrm{mM}$ during the initial phosphorylation burst, and that product inhibition by adenosine diphosphate (ADP) is negligible over the time window of interest.\n\nYou measure that in wild-type JAK at inhibitor concentration $I_0 = 50\\,\\mathrm{nM}$, with $K_m^{\\mathrm{WT}} = 250\\,\\mu\\mathrm{M}$, the initial phosphorylation rate of STAT (normalized to $V_\\mathrm{max}$) takes some value determined by the above conditions. A clinical mutation lowers the ATP Michaelis constant to $K_m^{\\mathrm{mut}} = 25\\,\\mu\\mathrm{M}$ while leaving $V_\\mathrm{max}$ unchanged. The inhibitor has $K_i = 5.0\\,\\mathrm{nM}$ and remains ATP-competitive in the mutant.\n\nUsing only core enzyme kinetic principles and the steady-state assumption appropriate to Michaelis–Menten analysis with competitive inhibition, determine the fold-change in inhibitor concentration required in the mutant, $I_{\\mathrm{mut}}/I_0$, to restore the same normalized initial phosphorylation rate (relative to $V_\\mathrm{max}$) as observed in the wild type at $I_0$. Round your answer to three significant figures.", "solution": "The problem statement has been validated and is deemed scientifically grounded, well-posed, and objective. It contains all necessary information and is structured as a standard problem in biochemical enzyme kinetics. We will therefore proceed with a rigorous solution.\n\nThe fundamental principle governing this system is the Michaelis-Menten equation, modified to account for competitive inhibition. The initial reaction velocity, $v$, is given by:\n$$ v = \\frac{V_{\\mathrm{max}} [S]}{K_m \\left(1 + \\frac{[I]}{K_i}\\right) + [S]} $$\nIn this problem, the substrate $S$ is adenosine triphosphate (ATP), and its concentration is given as $[\\mathrm{ATP}]$. The inhibitor concentration is $[I]$. The problem specifies that the peptide substrate is saturating, which justifies treating this as a single-substrate kinetic problem with respect to ATP. The term $V_{\\mathrm{max}}$ represents the maximum velocity, $K_m$ is the Michaelis constant for ATP, and $K_i$ is the dissociation constant for the inhibitor.\n\nThe quantity of interest is the normalized initial phosphorylation rate, defined as the ratio $\\frac{v}{V_{\\mathrm{max}}}$.\n$$ \\frac{v}{V_{\\mathrm{max}}} = \\frac{[\\mathrm{ATP}]}{K_m \\left(1 + \\frac{[I]}{K_i}\\right) + [\\mathrm{ATP}]} $$\nThe term in the denominator, $K_m \\left(1 + \\frac{[I]}{K_i}\\right)$, is the apparent Michaelis constant, $K_m^{\\mathrm{app}}$, which reflects the increased substrate concentration required to reach half-maximal velocity in the presence of a competitive inhibitor.\n\nThe problem requires us to find the inhibitor concentration for the mutant enzyme, $I_{\\mathrm{mut}}$, that results in the same normalized rate as observed for the wild-type (WT) enzyme under its specified inhibitor concentration, $I_0$. This condition can be expressed as:\n$$ \\left(\\frac{v}{V_{\\mathrm{max}}}\\right)_{\\mathrm{WT}} = \\left(\\frac{v}{V_{\\mathrm{max}}}\\right)_{\\mathrm{mut}} $$\nSubstituting the expression for the normalized rate into this equality gives:\n$$ \\frac{[\\mathrm{ATP}]}{K_m^{\\mathrm{WT}} \\left(1 + \\frac{I_0}{K_i}\\right) + [\\mathrm{ATP}]} = \\frac{[\\mathrm{ATP}]}{K_m^{\\mathrm{mut}} \\left(1 + \\frac{I_{\\mathrm{mut}}}{K_i}\\right) + [\\mathrm{ATP}]} $$\nSince $[\\mathrm{ATP}]$ is a fixed, non-zero concentration, and the numerators are identical, the denominators must be equal.\n$$ K_m^{\\mathrm{WT}} \\left(1 + \\frac{I_0}{K_i}\\right) + [\\mathrm{ATP}] = K_m^{\\mathrm{mut}} \\left(1 + \\frac{I_{\\mathrm{mut}}}{K_i}\\right) + [\\mathrm{ATP}] $$\nThe term $[\\mathrm{ATP}]$ cancels from both sides, yielding a more fundamental condition: the apparent Michaelis constants under the two scenarios must be identical to achieve the same degree of inhibition relative to the uninhibited enzyme.\n$$ K_m^{\\mathrm{WT}} \\left(1 + \\frac{I_0}{K_i}\\right) = K_m^{\\mathrm{mut}} \\left(1 + \\frac{I_{\\mathrm{mut}}}{K_i}\\right) $$\nOur objective is to find the fold-change $\\frac{I_{\\mathrm{mut}}}{I_0}$. We must first solve for $I_{\\mathrm{mut}}$.\n$$ 1 + \\frac{I_{\\mathrm{mut}}}{K_i} = \\frac{K_m^{\\mathrm{WT}}}{K_m^{\\mathrm{mut}}} \\left(1 + \\frac{I_0}{K_i}\\right) $$\n$$ \\frac{I_{\\mathrm{mut}}}{K_i} = \\frac{K_m^{\\mathrm{WT}}}{K_m^{\\mathrm{mut}}} \\left(1 + \\frac{I_0}{K_i}\\right) - 1 $$\n$$ I_{\\mathrm{mut}} = K_i \\left[ \\frac{K_m^{\\mathrm{WT}}}{K_m^{\\mathrm{mut}}} \\left(1 + \\frac{I_0}{K_i}\\right) - 1 \\right] $$\nExpanding the terms within the brackets:\n$$ I_{\\mathrm{mut}} = K_i \\left[ \\frac{K_m^{\\mathrm{WT}}}{K_m^{\\mathrm{mut}}} + \\frac{K_m^{\\mathrm{WT}}}{K_m^{\\mathrm{mut}}} \\frac{I_0}{K_i} - 1 \\right] $$\n$$ I_{\\mathrm{mut}} = \\frac{K_m^{\\mathrm{WT}}}{K_m^{\\mathrm{mut}}} I_0 + K_i \\left(\\frac{K_m^{\\mathrm{WT}}}{K_m^{\\mathrm{mut}}} - 1 \\right) $$\nTo find the required fold-change, we divide by $I_0$:\n$$ \\frac{I_{\\mathrm{mut}}}{I_0} = \\frac{K_m^{\\mathrm{WT}}}{K_m^{\\mathrm{mut}}} + \\frac{K_i}{I_0} \\left(\\frac{K_m^{\\mathrm{WT}}}{K_m^{\\mathrm{mut}}} - 1 \\right) $$\nNow, we substitute the provided values into this derived expression. The concentrations must be in consistent units for each ratio, but the ratios themselves are dimensionless.\nGiven:\n$K_m^{\\mathrm{WT}} = 250\\,\\mu\\mathrm{M}$\n$K_m^{\\mathrm{mut}} = 25\\,\\mu\\mathrm{M}$\n$I_0 = 50\\,\\mathrm{nM}$\n$K_i = 5.0\\,\\mathrm{nM}$\n\nWe calculate the necessary dimensionless ratios:\nThe ratio of Michaelis constants:\n$$ \\frac{K_m^{\\mathrm{WT}}}{K_m^{\\mathrm{mut}}} = \\frac{250\\,\\mu\\mathrm{M}}{25\\,\\mu\\mathrm{M}} = 10 $$\nThe ratio of the inhibitor constant to the initial inhibitor concentration:\n$$ \\frac{K_i}{I_0} = \\frac{5.0\\,\\mathrm{nM}}{50\\,\\mathrm{nM}} = 0.1 $$\nSubstituting these values into the expression for the fold-change:\n$$ \\frac{I_{\\mathrm{mut}}}{I_0} = 10 + (0.1) \\times (10 - 1) $$\n$$ \\frac{I_{\\mathrm{mut}}}{I_0} = 10 + (0.1) \\times 9 $$\n$$ \\frac{I_{\\mathrm{mut}}}{I_0} = 10 + 0.9 $$\n$$ \\frac{I_{\\mathrm{mut}}}{I_0} = 10.9 $$\nThe result is an exact value with three significant figures, as requested. This means that to achieve the same fractional inhibition in the mutant enzyme, which has a ten-fold higher affinity for ATP, the inhibitor concentration must be increased by a factor of $10.9$.", "answer": "$$\\boxed{10.9}$$", "id": "2545454"}]}